| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.1763 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.1763 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.2089 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.2511 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.3091 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.3215 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.3282 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.3398 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.3477 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.3813 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.4239 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5201 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5288 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5334 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5340 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5401 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5573 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5661 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5798 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5871 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.5887 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.6071 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.6080 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.6094 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.6162 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.6216 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7068 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7181 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7323 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7365 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7414 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7642 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.7844 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.8270 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.8428 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.8631 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.8961 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9118 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9132 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9176 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9337 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9576 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9642 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 0.9745 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.0255 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.0379 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.0961 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1035 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1125 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1315 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1564 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1747 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1783 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1805 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1827 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.1982 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.2357 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.2547 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.2590 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.2704 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.3379 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.3493 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.3922 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.4125 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.4496 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.5614 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.5702 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.5711 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.5895 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.6466 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.7621 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.7736 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 1.8397 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.0516 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.0980 | Peak area | Normal |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.1161 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.2329 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.2501 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.4520 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.4530 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.5167 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 2.5415 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 3.2560 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 3.6048 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 3.6666 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 3.9467 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | 2-arachidonoylglycerol (20:4) | 6.2504 | Peak area | Diabetic non neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|